Search information leaflets for human, veterinary and plants medications, drugs, supplements, herbal, nutritional and homoeopathic products;

Zelboraf

Zelboraf

Marketed by: Roche Registration GmbH
Active ingredient: vemurafenib

Available in: European Union
Language: English
Source: EMA - European Medicines Agency

Xeloda

Xeloda

Marketed by: Roche Registration GmbH
Active ingredient: capecitabine

Available in: European Union
Language: English
Source: EMA - European Medicines Agency

Trydonis

Trydonis

Marketed by: Chiesi Farmaceutici S.p.A.
Active ingredient: beclometasone dipropionate / formoterol fumarate dihydrate / glycopyrronium

Available in: European Union
Language: English
Source: EMA - European Medicines Agency

Truxima

Truxima

Marketed by: Celltrion Healthcare Hungary Kft.
Active ingredient: rituximab

Available in: European Union
Language: English
Source: EMA - European Medicines Agency

Truvada

Truvada

Marketed by: Gilead Sciences International Limited
Active ingredient: emtricitabine / tenofovir disoproxil fumarate

Available in: European Union
Language: English
Source: EMA - European Medicines Agency

Tobi Podhaler

Tobi Podhaler

Marketed by: Novartis Europharm Limited
Active ingredient: tobramycin

Available in: European Union
Language: English
Source: EMA - European Medicines Agency

Tecentriq

Tecentriq

Marketed by: Roche Registration GmbH
Active ingredient: atezolizumab

Available in: European Union
Language: English
Source: EMA - European Medicines Agency

Tasermity

Tasermity

Marketed by: Genzyme Europe BV
Active ingredient: sevelamer hydrochloride

Available in: European Union
Language: English
Source: EMA - European Medicines Agency

Steglujan

Steglujan

Marketed by: Merck Sharp & Dohme Limited
Active ingredient: ertugliflozin l-pyroglutamic acid / sitagliptin phosphate monohydrate

Available in: European Union
Language: English
Source: EMA - European Medicines Agency

Steglatro

Steglatro

Marketed by: Merck Sharp & Dohme Limited
Active ingredient: ertugliflozin l-pyroglutamic acid

Available in: European Union
Language: English
Source: EMA - European Medicines Agency

Segluromet

Segluromet

Marketed by: Merck Sharp & Dohme Limited
Active ingredient: ertugliflozin l-pyroglutamic acid / metformin hydrochloride

Available in: European Union
Language: English
Source: EMA - European Medicines Agency

Ristempa

Ristempa

Marketed by: Amgen Europe B.V.
Active ingredient: pegfilgrastim

Available in: European Union
Language: English
Source: EMA - European Medicines Agency

Riarify (previously CHF 5993 Chiesi Farmaceutici S.p.A.)

Riarify (previously CHF 5993 Chiesi Farmaceutici S.p.A.)

Marketed by: Chiesi Farmaceutici S.p.A.
Active ingredient: beclometasone dipropionate anhydrous / formoterol fumarate dihydrate / glycopyrronium

Available in: European Union
Language: English
Source: EMA - European Medicines Agency

Relvar Ellipta

Relvar Ellipta

Marketed by: Glaxo Group Ltd
Active ingredient: fluticasone furoate / vilanterol

Available in: European Union
Language: English
Source: EMA - European Medicines Agency

Raxone

Raxone

Marketed by: Santhera Pharmaceuticals (Deutschland) GmbH
Active ingredient: idebenone

Available in: European Union
Language: English
Source: EMA - European Medicines Agency

Qarziba (previously Dinutuximab beta EUSA and Dinutuximab beta Apeiron)

Qarziba (previously Dinutuximab beta EUSA and Dinutuximab beta Apeiron)

Marketed by: EUSA Pharma (UK) Limited
Active ingredient: dinutuximab beta

Available in: European Union
Language: English
Source: EMA - European Medicines Agency

ProQuad

ProQuad

Marketed by: MSD VACCINS
Active ingredient: virus, live attenuated, measles, virus, live attenuated, mumps, virus, live attenuated, rubella, virus, live attenuated, varicella

Available in: European Union
Language: English
Source: EMA - European Medicines Agency

Procoralan

Procoralan

Marketed by: Les Laboratoires Servier
Active ingredient: ivabradine hydrochloride

Available in: European Union
Language: English
Source: EMA - European Medicines Agency

Pritor

Pritor

Marketed by: Bayer AG
Active ingredient: telmisartan

Available in: European Union
Language: English
Source: EMA - European Medicines Agency

Perjeta

Perjeta

Marketed by: Roche Registration GmbH
Active ingredient: pertuzumab

Available in: European Union
Language: English
Source: EMA - European Medicines Agency

Pegasys

Pegasys

Marketed by: Roche Registration GmbH
Active ingredient: peginterferon alfa-2a

Available in: European Union
Language: English
Source: EMA - European Medicines Agency

Oprymea

Oprymea

Marketed by: Krka, d.d., Novo mesto
Active ingredient: pramipexole dihydrochloride monohydrate

Available in: European Union
Language: English
Source: EMA - European Medicines Agency

Onbrez Breezhaler

Onbrez Breezhaler

Marketed by: Novartis Europharm Limited
Active ingredient: indacaterol maleate

Available in: European Union
Language: English
Source: EMA - European Medicines Agency

Ocrevus

Ocrevus

Marketed by: Roche Registration GmbH
Active ingredient: ocrelizumab

Available in: European Union
Language: English
Source: EMA - European Medicines Agency

Nuwiq

Nuwiq

Marketed by: Octapharma AB
Active ingredient: simoctocog alfa

Available in: European Union
Language: English
Source: EMA - European Medicines Agency

NeoRecormon

NeoRecormon

Marketed by: Roche Registration GmbH
Active ingredient: epoetin beta

Available in: European Union
Language: English
Source: EMA - European Medicines Agency

Mylotarg

Mylotarg

Marketed by: Pfizer Limited
Active ingredient: gemtuzumab ozogamicin

Available in: European Union
Language: English
Source: EMA - European Medicines Agency

Lokelma

Lokelma

Marketed by: AstraZeneca AB
Active ingredient: sodium zirconium cyclosilicate

Available in: European Union
Language: English
Source: EMA - European Medicines Agency

Latuda

Latuda

Marketed by: Aziende Chimiche Riunite Angelini Francesco S.p.A.
Active ingredient: lurasidone

Available in: European Union
Language: English
Source: EMA - European Medicines Agency

Lamzede

Lamzede

Marketed by: Chiesi Farmaceutici S.p.A.
Active ingredient: velmanase alfa

Available in: European Union
Language: English
Source: EMA - European Medicines Agency

Lacosamide Accord

Lacosamide Accord

Marketed by: Accord Healthcare Ltd
Active ingredient: lacosamide

Available in: European Union
Language: English
Source: EMA - European Medicines Agency

Kinzalmono (previously Telmisartan Boehringer Ingelheim Pharma KG)

Kinzalmono (previously Telmisartan Boehringer Ingelheim Pharma KG)

Marketed by: Bayer AG
Active ingredient: telmisartan

Available in: European Union
Language: English
Source: EMA - European Medicines Agency